Use of acetylcysteine in bronchial asthma and emphysema.
D000111:Acetylcysteine / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001991:Bronchitis / Q000188:drug therapy; D002648:Child; D002908:Chronic Disease; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009093:Mucus / Q000378:metabolism; D011656:Pulmonary Emphysema / Q000188:drug therapy*; D012129:Respiratory Function Tests; D006255:Rhinitis, Allergic, Seasonal / Q000150:complications; D013501:Surface-Active Agents / Q000627:therapeutic use
D000336:Aerosols; D013501:Surface-Active Agents; D000431:Ethanol; D007545:Isoproterenol; D000111:Acetylcysteine